Hear from expert oncologists and pathologists how NGS-based comprehensive genomic profiling assays are changing the paradigm in oncology. On Demand recordings of ESMO Industry Satellite Symposium.
Phil Febbo
Chief Medical Officer
Illumina
Bernard Dogerde Spéville
Medical Oncologist
Fundación Jiménez Díaz
Wilko Weichert
Prof of Pathology
Technical University Munich
Details
Fill Out Form to Access Webinar
Your email address is never shared with third parties.
- Date & Time
- 22 Sep 2020
- Location
- Europe
- Topic
- Oncology